Merrill Boyle
Overview
Explore the profile of Merrill Boyle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
3717
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yanko O, Lytle A, Farinha P, Boyle M, Slack G, Scott D, et al.
Arch Pathol Lab Med
. 2025 Feb;
PMID: 39895007
Context.—: Aided by tissue microarray (TMA) technology, several RNA-correlated immunohistochemistry-based algorithms have been developed for cell-of-origin (COO) prediction in diffuse large B-cell lymphoma, not otherwise specified (DLBCL-NOS). However, there is...
2.
Alduaij W, Jiang A, Villa D, Collinge B, Collinge B, Ben-Neriah S, et al.
Blood
. 2024 Oct;
145(6):590-596.
PMID: 39441916
High-grade B-cell lymphoma with MYC and BCL2 rearrangements (HGBCL-DH-BCL2), or "double-hit lymphoma," has been associated with a high risk of central nervous system (CNS) relapse. However, historic estimates are impacted...
3.
Gunawardana J, Law S, Sabdia M, Fennell E, Hennessy A, Leahy C, et al.
Am J Hematol
. 2024 Aug;
99(11):2096-2107.
PMID: 39152767
In classical Hodgkin lymphoma (cHL), responsiveness to immune-checkpoint blockade (ICB) is associated with specific tumor microenvironment (TME) and peripheral blood features. The role of ICB in nodular lymphocyte predominant Hodgkin...
4.
Collinge B, Ben-Neriah S, Hilton L, Alduaij W, Tucker T, Slack G, et al.
Blood
. 2024 Aug;
144(15):1611-1616.
PMID: 39133931
Fluorescence in situ hybridization (FISH) using break-apart probes is recommended for identifying high-grade B-cell lymphoma with MYC and BCL2 rearrangements (HGBCL-DH-BCL2). Unbalanced MYC break-apart patterns, in which the red or...
5.
Hilton L, Collinge B, Ben-Neriah S, Alduaij W, Shaalan H, Weng A, et al.
Blood
. 2024 May;
144(5):525-540.
PMID: 38701426
Rearrangements that place the oncogenes MYC, BCL2, or BCL6 adjacent to superenhancers are common in mature B-cell lymphomas. Lymphomas with diffuse large B-cell lymphoma (DLBCL) or high-grade morphology with both...
6.
Grants J, May C, Bridgers J, Huang S, Gillis S, Meissner B, et al.
Clin Chem
. 2024 Jan;
70(1):273-284.
PMID: 38175592
Background: Somatic hypermutation (SHM) status of the immunoglobulin heavy variable (IGHV) gene plays a crucial role in determining the prognosis and treatment of patients with chronic lymphocytic leukemia (CLL). A...
7.
Aoki T, Jiang A, Xu A, Yin Y, Gamboa A, Milne K, et al.
J Clin Oncol
. 2023 Dec;
42(9):1077-1087.
PMID: 38113419
Purpose: About a third of patients with relapsed or refractory classic Hodgkin lymphoma (r/r CHL) succumb to their disease after high-dose chemotherapy followed by autologous stem-cell transplantation (HDC/ASCT). Here, we...
8.
Urata T, Naoi Y, Jiang A, Boyle M, Sunami K, Imai T, et al.
Blood Adv
. 2023 Aug;
7(24):7459-7470.
PMID: 37552496
The distribution and clinical impact of cell-of-origin (COO) subtypes of diffuse large B-cell lymphoma (DLBCL) outside Western countries remain unknown. Recent literature also suggests that there is an additional COO...
9.
Hilton L, Ngu H, Collinge B, Dreval K, Ben-Neriah S, Rushton C, et al.
J Clin Oncol
. 2023 Jun;
41(25):4164-4177.
PMID: 37319384
Purpose: Diffuse large B-cell lymphoma (DLBCL) is cured in more than 60% of patients, but outcomes remain poor for patients experiencing disease progression or relapse (refractory or relapsed DLBCL [rrDLBCL]),...
10.
Dreval K, Hilton L, Cruz M, Shaalan H, Ben-Neriah S, Boyle M, et al.
Blood
. 2023 Apr;
142(6):561-573.
PMID: 37084389
Follicular lymphoma (FL) accounts for ∼20% of all new lymphoma cases. Increases in cytological grade are a feature of the clinical progression of this malignancy, and eventual histologic transformation (HT)...